目次

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global ophthalmology therapeutics market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global ophthalmology therapeutics market 2017 - 2021 ($ billion)
4.2 Product Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
4.3 Type Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Retinal disorder therapeutics - Market size and forecast 2022-2027
Exhibit 34: Chart on Retinal disorder therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibit 35: Data Table on Retinal disorder therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibit 36: Chart on Retinal disorder therapeutics - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Retinal disorder therapeutics - Year-over-year growth 2022-2027 (%)
6.4 Glaucoma therapeutics - Market size and forecast 2022-2027
Exhibit 38: Chart on Glaucoma therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibit 39: Data Table on Glaucoma therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibit 40: Chart on Glaucoma therapeutics - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Glaucoma therapeutics - Year-over-year growth 2022-2027 (%)
6.5 Dry eye disease therapeutics - Market size and forecast 2022-2027
Exhibit 42: Chart on Dry eye disease therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibit 43: Data Table on Dry eye disease therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibit 44: Chart on Dry eye disease therapeutics - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Dry eye disease therapeutics - Year-over-year growth 2022-2027 (%)
6.6 Eye infections and inflammation therapeutics - Market size and forecast 2022-2027
Exhibit 46: Chart on Eye infections and inflammation therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibit 47: Data Table on Eye infections and inflammation therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibit 48: Chart on Eye infections and inflammation therapeutics - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Eye infections and inflammation therapeutics - Year-over-year growth 2022-2027 (%)
6.7 Other therapeutics - Market size and forecast 2022-2027
Exhibit 50: Chart on Other therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibit 51: Data Table on Other therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibit 52: Chart on Other therapeutics - Year-over-year growth 2022-2027 (%)
Exhibit 53: Data Table on Other therapeutics - Year-over-year growth 2022-2027 (%)
6.8 Market opportunity by Product
Exhibit 54: Market opportunity by Product ($ billion)

7 Market Segmentation by Type
7.1 Market segments
Exhibit 55: Chart on Type - Market share 2022-2027 (%)
Exhibit 56: Data Table on Type - Market share 2022-2027 (%)
7.2 Comparison by Type
Exhibit 57: Chart on Comparison by Type
Exhibit 58: Data Table on Comparison by Type
7.3 Prescription drugs - Market size and forecast 2022-2027
Exhibit 59: Chart on Prescription drugs - Market size and forecast 2022-2027 ($ billion)
Exhibit 60: Data Table on Prescription drugs - Market size and forecast 2022-2027 ($ billion)
Exhibit 61: Chart on Prescription drugs - Year-over-year growth 2022-2027 (%)
Exhibit 62: Data Table on Prescription drugs - Year-over-year growth 2022-2027 (%)
7.4 OTC drugs - Market size and forecast 2022-2027
Exhibit 63: Chart on OTC drugs - Market size and forecast 2022-2027 ($ billion)
Exhibit 64: Data Table on OTC drugs - Market size and forecast 2022-2027 ($ billion)
Exhibit 65: Chart on OTC drugs - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on OTC drugs - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Type
Exhibit 67: Market opportunity by Type ($ billion)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 69: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 71: Chart on Geographic comparison
Exhibit 72: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 81: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 82: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 83: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 93: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 94: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 95: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 97: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 98: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 99: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 France - Market size and forecast 2022-2027
Exhibit 101: Chart on France - Market size and forecast 2022-2027 ($ billion)
Exhibit 102: Data Table on France - Market size and forecast 2022-2027 ($ billion)
Exhibit 103: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibit 104: Data Table on France - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
Exhibit 105: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibit 106: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibit 107: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 108: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 109: Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 110: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 112: Overview on factors of disruption
11.4 Industry risks
Exhibit 113: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 114: Vendors covered
12.2 Market positioning of vendors
Exhibit 115: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 116: AbbVie Inc. - Overview
Exhibit 117: AbbVie Inc. - Product / Service
Exhibit 118: AbbVie Inc. - Key news
Exhibit 119: AbbVie Inc. - Key offerings
12.4 Aldeyra Therapeutics Inc.
Exhibit 120: Aldeyra Therapeutics Inc. - Overview
Exhibit 121: Aldeyra Therapeutics Inc. - Product / Service
Exhibit 122: Aldeyra Therapeutics Inc. - Key offerings
12.5 Bausch Health Co Inc.
Exhibit 123: Bausch Health Co Inc. - Overview
Exhibit 124: Bausch Health Co Inc. - Business segments
Exhibit 125: Bausch Health Co Inc. - Key news
Exhibit 126: Bausch Health Co Inc. - Key offerings
Exhibit 127: Bausch Health Co Inc. - Segment focus
12.6 Bayer AG
Exhibit 128: Bayer AG - Overview
Exhibit 129: Bayer AG - Business segments
Exhibit 130: Bayer AG - Key news
Exhibit 131: Bayer AG - Key offerings
Exhibit 132: Bayer AG - Segment focus
12.7 F. Hoffmann La Roche Ltd.
Exhibit 133: F. Hoffmann La Roche Ltd. - Overview
Exhibit 134: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 135: F. Hoffmann La Roche Ltd. - Key news
Exhibit 136: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 137: F. Hoffmann La Roche Ltd. - Segment focus
12.8 Novartis AG
Exhibit 138: Novartis AG - Overview
Exhibit 139: Novartis AG - Business segments
Exhibit 140: Novartis AG - Key offerings
Exhibit 141: Novartis AG - Segment focus
12.9 Ocular Therapeutix Inc.
Exhibit 142: Ocular Therapeutix Inc. - Overview
Exhibit 143: Ocular Therapeutix Inc. - Product / Service
Exhibit 144: Ocular Therapeutix Inc. - Key offerings
12.10 Otsuka Pharmaceutical Co. Ltd.
Exhibit 145: Otsuka Pharmaceutical Co. Ltd. - Overview
Exhibit 146: Otsuka Pharmaceutical Co. Ltd. - Product / Service
Exhibit 147: Otsuka Pharmaceutical Co. Ltd. - Key offerings
12.11 Oxurion NV
Exhibit 148: Oxurion NV - Overview
Exhibit 149: Oxurion NV - Product / Service
Exhibit 150: Oxurion NV - Key offerings
12.12 Pfizer Inc.
Exhibit 151: Pfizer Inc. - Overview
Exhibit 152: Pfizer Inc. - Product / Service
Exhibit 153: Pfizer Inc. - Key news
Exhibit 154: Pfizer Inc. - Key offerings
12.13 Regeneron Pharmaceuticals Inc.
Exhibit 155: Regeneron Pharmaceuticals Inc. - Overview
Exhibit 156: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibit 157: Regeneron Pharmaceuticals Inc. - Key offerings
12.14 Santen Pharmaceutical Co. Ltd.
Exhibit 158: Santen Pharmaceutical Co. Ltd. - Overview
Exhibit 159: Santen Pharmaceutical Co. Ltd. - Product / Service
Exhibit 160: Santen Pharmaceutical Co. Ltd. - Key offerings
12.15 Sun Pharmaceutical Industries Ltd.
Exhibit 161: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 162: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 163: Sun Pharmaceutical Industries Ltd. - Key offerings
12.16 Teva Pharmaceutical Industries Ltd.
Exhibit 164: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 165: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 166: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 167: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 168: Teva Pharmaceutical Industries Ltd. - Segment focus
12.17 Visufarma
Exhibit 169: Visufarma - Overview
Exhibit 170: Visufarma - Product / Service
Exhibit 171: Visufarma - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 172: Inclusions checklist
Exhibit 173: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 174: Currency conversion rates for US$
13.4 Research methodology
Exhibit 175: Research methodology
Exhibit 176: Validation techniques employed for market sizing
Exhibit 177: Information sources
13.5 List of abbreviations
Exhibit 178: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global ophthalmology therapeutics market 2017 - 2021 ($ billion)
Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Product - Market share 2022-2027 (%)
Exhibits31: Data Table on Product - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Retinal disorder therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on Retinal disorder therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on Retinal disorder therapeutics - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Retinal disorder therapeutics - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Glaucoma therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on Glaucoma therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on Glaucoma therapeutics - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Glaucoma therapeutics - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Dry eye disease therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibits43: Data Table on Dry eye disease therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibits44: Chart on Dry eye disease therapeutics - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Dry eye disease therapeutics - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Eye infections and inflammation therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibits47: Data Table on Eye infections and inflammation therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibits48: Chart on Eye infections and inflammation therapeutics - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Eye infections and inflammation therapeutics - Year-over-year growth 2022-2027 (%)
Exhibits50: Chart on Other therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibits51: Data Table on Other therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibits52: Chart on Other therapeutics - Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Other therapeutics - Year-over-year growth 2022-2027 (%)
Exhibits54: Market opportunity by Product ($ billion)
Exhibits55: Chart on Type - Market share 2022-2027 (%)
Exhibits56: Data Table on Type - Market share 2022-2027 (%)
Exhibits57: Chart on Comparison by Type
Exhibits58: Data Table on Comparison by Type
Exhibits59: Chart on Prescription drugs - Market size and forecast 2022-2027 ($ billion)
Exhibits60: Data Table on Prescription drugs - Market size and forecast 2022-2027 ($ billion)
Exhibits61: Chart on Prescription drugs - Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Prescription drugs - Year-over-year growth 2022-2027 (%)
Exhibits63: Chart on OTC drugs - Market size and forecast 2022-2027 ($ billion)
Exhibits64: Data Table on OTC drugs - Market size and forecast 2022-2027 ($ billion)
Exhibits65: Chart on OTC drugs - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on OTC drugs - Year-over-year growth 2022-2027 (%)
Exhibits67: Market opportunity by Type ($ billion)
Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits69: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits71: Chart on Geographic comparison
Exhibits72: Data Table on Geographic comparison
Exhibits73: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits74: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits75: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits78: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits79: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits82: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits83: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits90: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits91: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits94: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits95: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits98: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits99: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on France - Market size and forecast 2022-2027 ($ billion)
Exhibits102: Data Table on France - Market size and forecast 2022-2027 ($ billion)
Exhibits103: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibits106: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibits107: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits109: Market opportunity By Geographical Landscape ($ billion)
Exhibits110: Impact of drivers and challenges in 2022 and 2027
Exhibits111: Overview on Criticality of inputs and Factors of differentiation
Exhibits112: Overview on factors of disruption
Exhibits113: Impact of key risks on business
Exhibits114: Vendors covered
Exhibits115: Matrix on vendor position and classification
Exhibits116: AbbVie Inc. - Overview
Exhibits117: AbbVie Inc. - Product / Service
Exhibits118: AbbVie Inc. - Key news
Exhibits119: AbbVie Inc. - Key offerings
Exhibits120: Aldeyra Therapeutics Inc. - Overview
Exhibits121: Aldeyra Therapeutics Inc. - Product / Service
Exhibits122: Aldeyra Therapeutics Inc. - Key offerings
Exhibits123: Bausch Health Co Inc. - Overview
Exhibits124: Bausch Health Co Inc. - Business segments
Exhibits125: Bausch Health Co Inc. - Key news
Exhibits126: Bausch Health Co Inc. - Key offerings
Exhibits127: Bausch Health Co Inc. - Segment focus
Exhibits128: Bayer AG - Overview
Exhibits129: Bayer AG - Business segments
Exhibits130: Bayer AG - Key news
Exhibits131: Bayer AG - Key offerings
Exhibits132: Bayer AG - Segment focus
Exhibits133: F. Hoffmann La Roche Ltd. - Overview
Exhibits134: F. Hoffmann La Roche Ltd. - Business segments
Exhibits135: F. Hoffmann La Roche Ltd. - Key news
Exhibits136: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits137: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits138: Novartis AG - Overview
Exhibits139: Novartis AG - Business segments
Exhibits140: Novartis AG - Key offerings
Exhibits141: Novartis AG - Segment focus
Exhibits142: Ocular Therapeutix Inc. - Overview
Exhibits143: Ocular Therapeutix Inc. - Product / Service
Exhibits144: Ocular Therapeutix Inc. - Key offerings
Exhibits145: Otsuka Pharmaceutical Co. Ltd. - Overview
Exhibits146: Otsuka Pharmaceutical Co. Ltd. - Product / Service
Exhibits147: Otsuka Pharmaceutical Co. Ltd. - Key offerings
Exhibits148: Oxurion NV - Overview
Exhibits149: Oxurion NV - Product / Service
Exhibits150: Oxurion NV - Key offerings
Exhibits151: Pfizer Inc. - Overview
Exhibits152: Pfizer Inc. - Product / Service
Exhibits153: Pfizer Inc. - Key news
Exhibits154: Pfizer Inc. - Key offerings
Exhibits155: Regeneron Pharmaceuticals Inc. - Overview
Exhibits156: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibits157: Regeneron Pharmaceuticals Inc. - Key offerings
Exhibits158: Santen Pharmaceutical Co. Ltd. - Overview
Exhibits159: Santen Pharmaceutical Co. Ltd. - Product / Service
Exhibits160: Santen Pharmaceutical Co. Ltd. - Key offerings
Exhibits161: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits162: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits163: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits164: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits165: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits166: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits167: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits168: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits169: Visufarma - Overview
Exhibits170: Visufarma - Product / Service
Exhibits171: Visufarma - Key offerings
Exhibits172: Inclusions checklist
Exhibits173: Exclusions checklist
Exhibits174: Currency conversion rates for US$
Exhibits175: Research methodology
Exhibits176: Validation techniques employed for market sizing
Exhibits177: Information sources
Exhibits178: List of abbreviations